Merrill Matthews, Ph.D., is a resident scholar with the Institute for Policy Innovation, a research-based, public policy “think tank.” He is a health policy expert and opinion contributor at The Hill. He also serves on the Texas Advisory Committee of the U.S. Commission on Civil Rights.
Dr. Matthews is a past president of the Health Economics Roundtable for the National Association for Business Economics, the largest trade association of business economists. Dr. Matthews also served for 10 years as the medical ethicist for the University of Texas Southwestern Medical Center’s Institutional Review Board for Human Experimentation, co-author of On the Edge: America Faces the Entitlements Cliff, and has contributed chapters to several books, including Physician Assisted Suicide: Expanding the Debate and The 21st Century Health Care Leader and Stop Paying the Crooks (on Medicare fraud).
He has been published in numerous journals and newspapers, including The Wall Street Journal, Investor’s Business Daily, Barron’s, USA Today, Forbes magazine and the Washington Times. He was an award-winning political analyst for the USA Radio Network.
Dr. Matthews received his Ph.D. in Humanities from the University of Texas at Dallas.
When Will the Media Stop Shamelessly Prostrating Itself Before Hillary Clinton?
Journalists, when given the chance to interview Clinton, seem too enamored and thankful to be in the great lady’s presence to bring up her own role in undermining democracy.
The Biden Administration's Worthless, Counterproductive Plan to Fight Inflation
The Biden administration is struggling to find ways to lower gasoline prices; but the ideas it's considering would likely make the problem worse.
Four Signs Trump's Influence in the GOP Is Waning
Most former presidents followed the Washington example and stepped into the shadows for a while so the country could move on. Trump didn’t. As time moves on, he will eventually lose his grip on the GOP, and it’s already beginning to happen.
Drug Importation Is Still a Bad, and Deadly, Policy
For 20 years IPI has been warning that prescription drug importation schemes would allow counterfeit drugs to enter the U.S., and we are seeing their deadly effects.
Why Energy Companies Won't Produce
Companies expect that as soon as the current turmoil subsides, the Biden administration will shift back to hostile rhetoric, anti-energy legislative proposals, and oppositional regulatory policies.
ObamaCare Premium Hikes Are Making Democrats Sick
So, on top of all the inflation pain consumers are already experiencing with food, rent, medicine and especially gasoline, several million Americans will receive a notice that their ObamaCare premiums are going up significantly. And while taxpayers will still be subsidizing those premiums, the subsidies won’t be as generous as they have been
Cancelling Student Loan Debt Would Worsen Inflation
Biden's student loan cancellation ploy would exacerbate inflation by putting even more money in the pockets of millions of Americans, most of whom don't need the additional cash.
Dark Cloud Falling: State and Local Pension Funds Are Struggling--Again
Once again a tanking stock market is threatening the financial stability of most state and local public employee pensions. Here's an alternative that would solve that problem.
An End to the Wussification of the Corporate CEO?
CEOs used to avoid alienating customers by speaking on political and social issues; but they have the right and expertise to speak out when President Biden makes ludicrous economic claims.
Total Records: 1699
